Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) issued its earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04), Yahoo Finance reports. The business had revenue of $2.42 million during the quarter, compared to the consensus estimate of $3.50 million. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%.

Pharma-Bio Serv Stock Performance

OTCMKTS:PBSV opened at $0.63 on Wednesday. Pharma-Bio Serv has a twelve month low of $0.52 and a twelve month high of $1.09. The company has a fifty day moving average of $0.62 and a 200-day moving average of $0.69.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.